Literature DB >> 10895752

Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics?

S G Sakka1, A Meier-Hellmann, K Reinhart.   

Abstract

We studied global and splanchnic haemodynamics in patients with septic shock, while reducing norepinephrine doses by progressive fluid loading administration. Ten patients (six female, four male, aged 39-86 yr, mean 61 yr) were assessed using a transpulmonary thermo-dye dilution technique to measure cardiac output, intrathoracic blood volume and total blood volume. Splanchnic blood flow was measured by the steady state indocyanine green technique using a hepatic venous catheter. Gastric mucosal blood flow was estimated by regional carbon dioxide tension (PRCO2). Hydroxyethylstarch was infused in two stages while maintaining mean arterial pressure, allowing a reduction in norepinephrine dose from 0.54 to 0.33 to 0.21 microgram kg-1 min-1. Mean (SD) heart rate significantly decreased, from 104 (13) to 94 (15) beats min-1. Total blood volume index (mean (SD)) increased from 2650 (638) to 3655 (885) ml m-2, intrathoracic blood volume index from 888 (204) to 1050 (248) ml m-2 and cardiac index from 3.6 (1.0) to 4.0 (0.9) litres min-1 m-2. Splanchnic blood flow did not change significantly--either absolute (from 0.81 to 0.98 litres min-1 m-2) or fractional (from 22.3% to 23.9%). Gastric mucosal (PRCO2) increased from 7.5 (2.5) to 9.0 (2.8) kPa. The PCO2 gap, i.e. the difference between regional and end-tidal PCO2, increased from 3.1 (2.5) to 4.0 (2.9) kPa. Marked individual variation in responses suggests that norepinephrine dose reduction by fluid loading in patients with stabilized septic shock does not necessarily increase global or splanchnic blood flow.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10895752     DOI: 10.1093/oxfordjournals.bja.a013589

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

Review 1.  [Volume replacement in intensive care medicine].

Authors:  B Nohé; A Ploppa; V Schmidt; K Unertl
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

2.  Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects.

Authors:  Giuseppe Natalini; Valeria Schivalocchi; Antonio Rosano; Maria Taranto; Cristina Pletti; Achille Bernardini
Journal:  Intensive Care Med       Date:  2005-04-01       Impact factor: 17.440

3.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

4.  Effects of fluid challenge on gastric mucosal PCO2 in septic patients.

Authors:  Eliézer Silva; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

5.  Effects of norepinephrine alone and norepinephrine plus dopamine on human intestinal mucosal perfusion.

Authors:  Andreas Nygren; Anders Thorén; Sven-Erik Ricksten
Journal:  Intensive Care Med       Date:  2003-07-15       Impact factor: 17.440

Review 6.  Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data.

Authors:  Neil J Glassford; Glenn M Eastwood; Rinaldo Bellomo
Journal:  Crit Care       Date:  2014-12-27       Impact factor: 9.097

Review 7.  Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock.

Authors:  Pierre Asfar; Daniel De Backer; Andreas Meier-Hellmann; Peter Radermacher; Samir G Sakka
Journal:  Crit Care       Date:  2003-12-29       Impact factor: 9.097

8.  Effects of volume resuscitation on splanchnic perfusion in canine model of severe sepsis induced by live Escherichia coli infusion.

Authors:  Claudio Esteves Lagoa; Luiz Francisco Poli de Figueiredo; Ruy Jorge Cruz; Eliézer Silva; Maurício Rocha e Silva
Journal:  Crit Care       Date:  2004-05-27       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.